Therapy with human recombinant erythropoietin in patients with myelodysplastic syndromes

Br J Haematol. 1992 Aug;81(4):628-30. doi: 10.1111/j.1365-2141.1992.tb03014.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Erythropoietin